Glimepiride
- Product NDC
- 43063-587
- 11-digit product format
- 430630587
- Labeler code
- 43063
- Product ID
- 43063-587_47d2591f-0089-44e7-e063-6294a90a7271
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glimepiride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Application
- ANDA078181
- Marketing category
- ANDA
- Marketing start
- 2007-08-23
- Substance
- GLIMEPIRIDE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A078181-001 | GLIMEPIRIDE | GLIMEPIRIDE | 1MG | TABLET / ORAL | AB | 2007-08-23 | |
| A078181-002 | GLIMEPIRIDE | GLIMEPIRIDE | 2MG | TABLET / ORAL | AB | 2007-08-23 | |
| A078181-003 | GLIMEPIRIDE | GLIMEPIRIDE | 4MG | TABLET / ORAL | AB | 2007-08-23 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A078181-001 | AB |
| A078181-002 | AB |
| A078181-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A078181-001 | GLIMEPIRIDE | 1MG | TABLET / ORAL | AB | 2007-08-23 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A078181-002 | GLIMEPIRIDE | 2MG | TABLET / ORAL | AB | 2007-08-23 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A078181-003 | GLIMEPIRIDE | 4MG | TABLET / ORAL | AB | 2007-08-23 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A078181-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A078181-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A078181-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glimepiride | GLIMEPIRIDE | Bryant Ranch Prepack | 9e863f84-d6f2-4d61-8250-774569e84353 | 2026-05-19 | Warnings, Adverse reactions | 078181 ANDA078181 |
| Glimepiride | GLIMEPIRIDE | PD-Rx Pharmaceuticals, Inc. | 58c4261e-e98f-4280-9562-2800956dff14 | 2026-01-07 | Warnings, Adverse reactions | 078181 ANDA078181 43063-587 |
| Glimepiride | GLIMEPIRIDE | PD-Rx Pharmaceuticals, Inc. | 1b3c7d74-f80b-4fb1-8dca-66880af5d3fc | 2026-01-07 | Warnings, Adverse reactions | 078181 ANDA078181 |
| Glimepiride | GLIMEPIRIDE | Northwind Health Company, LLC | 3e81a39a-30bb-4d6d-82e1-17d7134365be | 2026-01-01 | Warnings, Adverse reactions | 078181 ANDA078181 |
| Glimepiride | GLIMEPIRIDE | Northwind Health Company, LLC | f2f2d6da-eb40-4290-e053-2a95a90a6ca0 | 2026-01-01 | Warnings, Adverse reactions | 078181 ANDA078181 |
| Glimepiride | GLIMEPIRIDE | Accord Healthcare Inc | 9b74fbac-9e04-4927-9981-1e3dace89c6d | 2025-10-17 | Warnings, Adverse reactions | 078181 ANDA078181 |
| Glimepiride | GLIMEPIRIDE | Proficient Rx LP | beb0cefb-807b-4cc3-ada2-7a8ed4aa8f2b | 2022-10-01 | Warnings, Adverse reactions | 078181 ANDA078181 |
| Glimepiride | GLIMEPIRIDE | Proficient Rx LP | 5a5747ea-cded-49ed-8807-dd3e2a1159e0 | 2022-10-01 | Warnings, Adverse reactions | 078181 ANDA078181 |
| Glimepiride | GLIMEPIRIDE | Proficient Rx LP | 68cb4fcd-5bc3-4f53-9085-86df6a4246d6 | 2022-04-01 | Warnings, Adverse reactions | 078181 ANDA078181 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Glimepiride
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| GLIMEPIRIDE | 4 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 6KY687524K | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 199247 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 58c4261e-e98f-4280-9562-2800956dff14 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| b890b964-2cf0-4439-aaf3-900c9e3e9e49 | Product name | 1 | 20160602 |
| 7611093e-8875-33d4-9e3c-f48c7e3af1e8 | Product name | 1 | 20140508 |
| d36d861f-8a90-80cc-8935-1e6be9b4c7eb | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 43063-587-30 | Glimepiride | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | 18 | |
| 43063-587-90 | Glimepiride | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 18 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 43063-587-30 | EA - Each | 43063-587 | 2f99ec76-c315-48c5-b753-4603c4975c56 | 1 | 2017-03-06 |
| 43063-587-90 | EA - Each | 43063-587 | 85a9b424-221b-4713-b741-462308edf261 | 1 | 2015-09-10 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| GLIMEPIRIDE | ACTIVE INGREDIENT | 6KY687524K | GLIMEPIRIDE TABLET [PD-RX PHARMACEUTICALS, INC.] | 5 | |
| GLIMEPIRIDE | ACTIVE MOIETY | 6KY687524K | GLIMEPIRIDE TABLET [PD-RX PHARMACEUTICALS, INC.] | 5 | |
| FD&C BLUE NO. 2 | INACTIVE INGREDIENT | L06K8R7DQK | GLIMEPIRIDE TABLET [PD-RX PHARMACEUTICALS, INC.] | 5 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | GLIMEPIRIDE TABLET [PD-RX PHARMACEUTICALS, INC.] | 5 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | GLIMEPIRIDE TABLET [PD-RX PHARMACEUTICALS, INC.] | 5 | |
| POVIDONE | INACTIVE INGREDIENT | FZ989GH94E | GLIMEPIRIDE TABLET [PD-RX PHARMACEUTICALS, INC.] | 5 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | GLIMEPIRIDE TABLET [PD-RX PHARMACEUTICALS, INC.] | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 199247 | glimepiride 4 MG Oral Tablet | PSN | 58c4261e-e98f-4280-9562-2800956dff14 | 18 |
| 199247 | glimepiride 4 MG Oral Tablet | SCD | 58c4261e-e98f-4280-9562-2800956dff14 | 18 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 43063-587-30 | 43063058730 | 30 TABLET in 1 BOTTLE, PLASTIC (43063-587-30) | 30 tablet | 2017-01-11 | 0000-00-00 | No | No | Current |
| 43063-587-90 | 43063058790 | 90 TABLET in 1 BOTTLE, PLASTIC (43063-587-90) | 90 tablet | 2015-07-29 | 0000-00-00 | No | No | Current |